DK1578406T3 - Farmaceutisk sammensætning med modificeret frigivelse - Google Patents

Farmaceutisk sammensætning med modificeret frigivelse

Info

Publication number
DK1578406T3
DK1578406T3 DK03777508T DK03777508T DK1578406T3 DK 1578406 T3 DK1578406 T3 DK 1578406T3 DK 03777508 T DK03777508 T DK 03777508T DK 03777508 T DK03777508 T DK 03777508T DK 1578406 T3 DK1578406 T3 DK 1578406T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
modified release
release pharmaceutical
coated
granulate
Prior art date
Application number
DK03777508T
Other languages
Danish (da)
English (en)
Inventor
Janez Kerc
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200200318A external-priority patent/SI21349A/sl
Priority claimed from SI200300246A external-priority patent/SI21602A/sl
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of DK1578406T3 publication Critical patent/DK1578406T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03777508T 2002-12-24 2003-12-23 Farmaceutisk sammensætning med modificeret frigivelse DK1578406T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200200318A SI21349A (sl) 2002-12-24 2002-12-24 Plavajoča farmacevtska oblika s prirejenim sproščanjem zdravilne učinkovine
SI200300246A SI21602A (sl) 2003-09-24 2003-09-24 Plavajoča farmacevtska oblika s prirejenim sproščanjem zdravilne učinkovine
PCT/SI2003/000048 WO2004058230A1 (en) 2002-12-24 2003-12-23 Modified release pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK1578406T3 true DK1578406T3 (da) 2008-09-08

Family

ID=32684373

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03777508T DK1578406T3 (da) 2002-12-24 2003-12-23 Farmaceutisk sammensætning med modificeret frigivelse

Country Status (15)

Country Link
US (1) US7485322B2 (pt)
EP (1) EP1578406B1 (pt)
AT (1) ATE396712T1 (pt)
AU (1) AU2003286994A1 (pt)
BR (1) BRPI0317682B1 (pt)
CA (1) CA2509976C (pt)
DE (1) DE60321386D1 (pt)
DK (1) DK1578406T3 (pt)
EA (1) EA011373B1 (pt)
ES (1) ES2305537T3 (pt)
MX (1) MXPA05006916A (pt)
PL (1) PL207776B1 (pt)
PT (1) PT1578406E (pt)
SI (1) SI1578406T1 (pt)
WO (1) WO2004058230A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007112579A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Drug delivery composition
CN101453993A (zh) * 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
PL216542B1 (pl) * 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
US9284307B2 (en) 2009-08-05 2016-03-15 Idenix Pharmaceuticals Llc Macrocyclic serine protease inhibitors
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
MX2012006877A (es) 2009-12-18 2012-08-31 Idenix Pharmaceuticals Inc Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
JP5933554B2 (ja) 2010-09-01 2016-06-15 アムビト ビオスシエンセス コルポラチオン 光学活性のあるピラゾリルアミノキナゾリン及びその医薬組成物及び使用方法
AU2011296046B2 (en) 2010-09-01 2015-05-14 Ambit Biosciences Corporation Hydrobromide salts of a pyrazolylaminoquinazoline
BR112013014021A8 (pt) 2010-12-06 2017-10-03 Follica Inc Métodos para tratamento de calvície e promoção de crescimento de cabelos
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
CN103338753A (zh) 2011-01-31 2013-10-02 细胞基因公司 胞苷类似物的药物组合物及其使用方法
AR085352A1 (es) 2011-02-10 2013-09-25 Idenix Pharmaceuticals Inc Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
AU2012322323B2 (en) 2011-10-11 2016-04-21 Sun Pharmaceutical Industries Limited A gastroretentive dosage system and process of preparation thereof
RU2014141674A (ru) 2012-03-16 2016-05-10 Аксикин Фармасьютикалз, Инк. 3,5-диаминопиразоловые ингибиторы киназы
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
EP3046924A1 (en) 2013-09-20 2016-07-27 IDENIX Pharmaceuticals, Inc. Hepatitis c virus inhibitors
WO2015134560A1 (en) 2014-03-05 2015-09-11 Idenix Pharmaceuticals, Inc. Solid forms of a flaviviridae virus inhibitor compound and salts thereof
JP6568926B2 (ja) 2014-03-20 2019-08-28 カペラ セラピューティクス，インコーポレーテッド 癌の治療のためのｅｒｂｂチロシンキナーゼ阻害剤としてのベンゾイミダゾール誘導体
KR102663309B1 (ko) 2014-03-20 2024-05-03 카펠라 테라퓨틱스, 인크. 암 치료용의 ｅｒｂｂ 티로신 키나제 억제제로서의 벤즈이미다졸 유도체
UA118312C2 (uk) 2014-12-23 2018-12-26 Ексікін Фармасутікалз, Інк. 3,5-діамінопіразолові інгібітори кінази
CN107007838B (zh) * 2016-09-30 2021-07-20 南京优科制药有限公司 一种含有马来酸依那普利、叶酸和酸稳定剂的药物组合物
CN113768898A (zh) * 2021-09-14 2021-12-10 江苏万邦生化医药集团有限责任公司 悬浮的胶囊片

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815902A (en) * 1927-07-16 1931-07-28 Nat Aniline & Chem Co Inc Device for administering medicaments
US2340037A (en) * 1941-09-08 1944-01-25 Zipper Alfred Irving Capsule
US3186910A (en) * 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
JPS5512411B2 (pt) * 1974-03-12 1980-04-02
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4601896A (en) * 1984-03-21 1986-07-22 Mark Nugent Pharmaceutical capsule compositions and structures for gastric sensitive materials
DE3627423A1 (de) 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5387421A (en) * 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
JP2959423B2 (ja) 1994-12-01 1999-10-06 シオノギクオリカプス株式会社 カプセル用皮膜組成物
JP2001524131A (ja) 1997-05-09 2001-11-27 セイジ、ファーマスーティカルズ、インク 安定な経口医薬品剤形
AU757343B2 (en) * 1998-09-28 2003-02-20 Capsugel Belgium Nv Enteric and colonic delivery using HPMC capsules
US7163693B1 (en) * 1999-07-30 2007-01-16 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US20030194428A1 (en) * 2002-04-10 2003-10-16 Miller Frederick H. Process for encapsulating multi-phase, multi-compartment capsules

Also Published As

Publication number Publication date
WO2004058230A1 (en) 2004-07-15
DE60321386D1 (de) 2008-07-10
MXPA05006916A (es) 2005-08-18
PL207776B1 (pl) 2011-01-31
SI1578406T1 (sl) 2009-02-28
US20040131669A1 (en) 2004-07-08
AU2003286994A1 (en) 2004-07-22
PT1578406E (pt) 2008-09-01
PL376099A1 (en) 2005-12-12
ATE396712T1 (de) 2008-06-15
ES2305537T3 (es) 2008-11-01
US7485322B2 (en) 2009-02-03
BRPI0317682B1 (pt) 2015-04-14
CA2509976C (en) 2012-03-13
EA011373B1 (ru) 2009-02-27
CA2509976A1 (en) 2004-07-15
BR0317682A (pt) 2005-11-29
EP1578406B1 (en) 2008-05-28
EP1578406A1 (en) 2005-09-28
EA200500909A1 (ru) 2006-02-24

Similar Documents

Publication Publication Date Title
DK1578406T3 (da) Farmaceutisk sammensætning med modificeret frigivelse
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
MXPA03007712A (es) Sales farmaceuticas.
EA200501586A1 (ru) Фармацевтические продукты
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
HUP0402280A2 (hu) Mikronizált filmképző por, az ezt tartalmazó készítmények, eljárások ezek előállítására, és ezek alkalmazása
SI1532149T1 (sl) amino piperidin il ksantini njihova priprava in njihova uporaba kot zdravila
WO2007010034A3 (de) Ampholytisches copolymer, dessen herstellung und verwendung
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
DE60205749D1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
AR033711A1 (es) Composiciones farmaceuticas
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
WO2005007137A3 (de) Ambroxolhaltige tabletten
HUP0401200A2 (hu) Terbinafint tartalmazó gyógyszerészeti összetételek és eljárás előállításukra
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
ECSP066872A (es) Tabletas desintegrantes que comprenden licarbazepina
BRPI0611526A2 (pt) composição tópica contendo gelatina
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
ATE409040T1 (de) Kombination enthaltend substanzen mit npy- rezeptor affinität und substanzen mit 5-ht6- rezeptor affinität
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
WO2004024128A3 (en) Modified release ketoprofen dosage form
EA200100802A1 (ru) Применение тианептина при приготовлении лекарственных средств, предназначенных для лечения нейродегенеративных патологий
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
UA87291C2 (ru) Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения